UCAR T-cell Therapy Targeting CD19/BCMA in Patients With r/r Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Systemic Lupus Erythematosus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The first affiliated hospital of medical college of zhejiang university, Hangzhou, Zhejiang, China
Contact: Study coordinator (He Huang) · hehuangyu@126.com · 86-13605714822
Contact: Principal Investigator (He Huang)
Contact: Principal Investigator (Yongxian Hu)
Contact: Principal Investigator (Jin Lin)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Rheumatoid Arthritis · Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Fullerton, United States

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

Systemic Lupus Erythematosus

Abroad (travel likely)RecruitingPHASE1

Scottsdale, United States · Aurora, United States

US Zamto-cel Autoimmune Diseases

Lupus Nephritis · Systemic Lupus Erythematosus · Systemic Sclerosis (SSc)

Abroad (travel likely)RecruitingPHASE1

Milwaukee, United States

Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases

Autoimmune Diseases · Systemic Lupus Erythematosus · Systemic Sclerosis

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China